Reversal of Gastric Somatostatin Receptor Inhibition by Helicobacter pylori Lipopolysaccharide with Ebrotidine and Sulglycotide

Author： Piotrowski J.   Skrodzka D.   Slomiany A.   Slomiany B.L.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.28, Iss.5, 1997-05, pp. : 705-708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Gastric Mucosal Mucin Receptor by H. pylori Lipopolysaccharide: Effect of Ebrotidine

By Slomiany B.L.   Piotrowski J.   Murty V.L.N.   Slomiany A.  

General Pharmacology, Vol. 26, Iss. 7, 1995-11 ,pp. : 1553-1558

Elsevier

Access to resources Recommend Favorite

Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide - a matter of self control

By Slomiany B.L.   Piotrowski J.   Slomiany A.  

General Pharmacology, Vol. 32, Iss. 2, 1999-02 ,pp. : 251-257

Elsevier

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor  activation counters the detrimental effect of Helicobacter pylori lipopolysaccharide on gastric mucin synthesis

By Slomiany B. L.   Slomiany A.  

Inflammopharmacology, Vol. 11, Iss. 3, 2003-09 ,pp. : 223-236

VSP

Access to resources Recommend Favorite

Embryonal Cardiotoxicity of the Helicobacter pylori Lipopolysaccharide

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 1, 2001-05 ,pp. : 31-44

Bentham Science Publishers

Access to resources Recommend Favorite

Enhancement in the Protective Qualities of Gastric Mucus with Combination Therapy of Ebrotidine and Amoxicillin for H. pylori Eradication - effect of ebrotidine and ranitidine

By Slomiany B.L.   Piotrowski J.   Slomiany   Konturek W.   Domschke W.W.  

General Pharmacology, Vol. 31, Iss. 2, 1998-08 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite